KCAS-blog-thumb_discovery-bioanalysis Blogs
Read article Drug Discovery: an Essential Part of the Drug Development Process

Drug discovery is an essential part of the drug development process. Testing in drug discovery is the mechanism to provide drug candidates that are selected for regulated animal studies and hopefully moving into clinical trials.

PATTERN_ORANGE_1320x780 Webinars
View webinar KCAS Webinar Archive: “Optimizing Your CRO Selection Process for Pharmaceutical Drug Discovery”

If you missed our webinar on April 22nd of 2020, you can check it out below! Often, when confronted with outsourcing and looking for laboratories for your discovery projects, turnaround times and cost are two very important factors. Quality and reliability of data generated are of course essential as well. How do you…

PATTERN_BLUE_1320x780_3 Blogs
Read article Powder-to-Report: An Introduction to the Full Suite of Discovery Services at KCAS

There is a new and growing focus on drug development at KCAS. Our clients – both pharma and biotech research organizations – have depended on KCAS to provide bioanalytical services for over four decades.

KCAS-Blog_Thumbnail-Banner_DiscoveryDrugProcess Blogs
Read article Navigating the Twists and Turns of the Discovery Drug Development Process

At KCAS, our Discovery group performs bioanalytical / biomarker method development that can include any of the various components required for a validated method under the GLP guidelines.  So why is Discovery group needed?  The beginning stage of drug development is a stage of trial and error.  It is generally…

PATTERN_ORANGE_1320x780_3 Blogs
Read article Limited Sample Sizes: Doing a Lot; Even with a Little

Have you ever wished you could tailor your project to your research needs instead of taking what you can get from a CRO?  Here at KCAS, our Discovery team prides itself on having the flexibility to meet client’s needs by designing the experiments with feedback from our sponsors. Our team of…

PATTERN_ORANGE_1320x780_2 Blogs
Read article Bioanalytical Strategy Across the Drug Development Paradigm

At KCAS, we work with Director, VP, and C-level pharmaceutical and biotech executives that need to measure their drug or the effect of their drug in biological matrix. Many of our customers rely on…

PATTERN_AMBER_1320x780 Blogs
Read article Solving Discovery Bottlenecks at KCAS

Everyone likes to claim they offer fast turnaround times, but clients often come to KCAS having been burned by the lack of timeliness on their Discovery projects. At KCAS, we incorporate our clients’ priorities at the top of our priorities. We have put together a Discovery team with decades of…